An RSV vaccine has been available to pregnant women in Northern Ireland since last September and is offered from 28 weeks of ...

About 30,000 youngsters are admitted to hospital with the virus every year in the UK, with about 30 babies dying ...

A LUNG virus that can be deadly in babies has plummeted by 72 per cent thanks to a new vaccine. It’s the first real world ...

A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...

The new injection, Nirsevimab, will be given to high-risk babies, including those born too early to be protected by the RSV ...

Researchers looked at the cases of 537 babies in England and Scotland who were admitted to hospital with severe respiratory ...

A new CHOP study found only one in three eligible patients took Beyfortus when the medication that protects against severe ...

Child mortality has been halved in the last 25 years. Building on this progress, new innovations in immunization are working ...

The FDA has accepted for review the sBLA to expand the indication of Arexvy (RSV vaccine, adjuvanted) to adults aged 18 to 49 years who are at increased risk.

RSV has outstripped severe Covid and flu hospitalisation rates and proved itself more fatal than either of the flu season ...

British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the ...

FDA accepts GSK's application to expand Arexvy vaccine use to at-risk adults aged 18–49, with a decision expected in the ...